Telomolecular Corp Watch

from SB-2/A ~1 page Telomolecular Corp. Corporate Summary as of March 10, 2006

from SB-2 ~5 pages Support Documents

from SB-2 ~20 pages Exclusive Sublicense Agreement Unemed Corporation and Telomolecular Corp. Effective January 16, 2006 Exclusive Sublicense Agreement

from SB-2 ~20 pages Goverment Interests

from SB-2 ~5 pages Exclusive Agreement

from SB-2 ~10 pages 2004 to Present - Research Scientist * Responsible for Array Cgh Studies on Renal Cancer Using Illumina Whole Genome Beadarray Technology. * Responsible for Develop New Research Projects on New Biomarkers for Cancer. * Responsible for Identifying Prognosis Markers on Non-Small Cell Lung Cancer Using Taqman Real-Time Pcr. * Responsible for Identifying Genetic Risk Markers for Lung Cancer and Bladder Cancer Using Snplex, Taqman and Illumina Genotyping Techniques. * Responsible for Identifying Phenotypic Risk Markers for Renal Cancer and Lung Cancer Using Comet Assay and Fish. * Responsible for Genetic Association Study Using Illumina Gene Chip Array. * Lead Scientist Responsible for the Analysis, Design, Troubleshooting and Support in the Laboratory. * Published Four Papers and Two Abstracts for My Research

from SB-2 ~10 pages On Behalf of Dr. Vinod Labhasetwar at the University of Nebraska Medical Center, Enclosed Are Two (2) Agreements for the Above Referenced Project. Please Have the Appropriate Institutional Signatory Review and Sign the Agreements and Return One (1) Fully Executed Agreement to Me at the Sponsored Programs Administration Office at the Address Listed Below. if We May Provide Further Information or Assistance Concerning the Administration of This Project, Please Feel Free to Contact Me at 402/559-2174 Sincerely, Karalyn A. Schmidt Grants and Contracts Specialist Sponsored Programs Administration 987835 Nebraska Medical Center Omaha, Ne 68198-7835 University of Nebraska Medical Center Enclosures (2) CC: Dr. Labhasetwar - 6025 E. Payne - 6025 D. Loibl - 6025 Agreement Between Telomolecular (Hereinafter Referred to as Sponsor) and the Board of Regents of the University of Nebraska D/Bla the University of Nebraska Medical Center

from SB-2 1 page La Letter of Intent

from SB-2 ~20 pages Lease Agreement

from SB-2 ~1 page Telomolecular Corp. Corporate Summary as of March 10, 2006

from SB-2 1 page Certificate of Incorporation of Telomolecular Corp